GT Biopharma, Inc. — Form D

GT Biopharma, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-31. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Anshuman DubeDirectorLas Vegas, NV
Kenneth EatonDirectorBeverly Hills, CA
David SaloffDirectorBeverly Hills, CA
Kenneth EatonExecutive OfficerBeverly Hills, CA
Michael BreenDirectorSAN FRANCISCO, CA
Michael BreenExecutive OfficerSAN FRANCISCO, CA
Alan UrbanExecutive OfficerSAN FRANCISCO, CA
Hilary KramerDirectorSAN FRANCISCO, CA
Charles CasamentoDirectorSAN FRANCISCO, CA
Andrew RitterDirectorSAN FRANCISCO, CA
Bruce WendelDirectorSan Francisco, CA
Rajesh ShrotriyaDirectorSan Francisco, CA
Steven WeldonDirectorBeverly Hills, CA
Steven WeldonExecutive OfficerBeverly Hills, CA
Anthony CataldoDirectorBeverly Hills, CA
Anthony CataldoExecutive OfficerBeverly Hills, CA
Kathleen J Clarence-SmithDirectorTAMPA, FL
Kathleen J Clarence-SmithExecutive OfficerTAMPA, FL
Anthony J CataldoDirectorTAMPA, FL
Jon B BonfiglioDirectorTAMPA, FL
Raymond B UrbanskiExecutive OfficerTAMPA, FL
Peter B KienerDirectorTAMPA, FL
Geoffrey B DavisDirectorTAMPA, FL
Kathleen Clarence-SmithDirectorWashington, DC
Kathleen Clarence-SmithExecutive OfficerWashington, DC

Other filings by this issuer (10)

FiledFormOfferingSold
2025-05-28D$20.0M
2025-05-27D$6.0M$6.0M
2025-03-07D$1.3M$1.3M
2020-07-23D/A$5.6M
2020-06-12D$2.4M
2018-08-17D$5.1M$5.1M
2018-02-06D$7.1M$7.1M
2017-09-14D$4.5M$4.5M
2015-07-27D$1.5M$500K
2015-03-16D$3.0M$2.0M

More